NERVMinerva Neurosciences, Inc.

$51M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-2.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$161M

Total Liabilities

$50M

Stockholders' Equity

$111M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$13M	-$10M	-32.7%
Net Income	-$13M	-$10M	-28.1%

NERV Q2 2018 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena